About My Health Careers Internship MedBlogs Contact us

Scientists Identify New Drug Target Against Virulent Type of Breast Cancer

by Rajashri on August 26, 2008 at 7:03 PM
Font : A-A+

 Scientists Identify New Drug Target Against Virulent Type of Breast Cancer

An enzyme called Brk - shown to be an accelerator of HER2-positive tumours - may serve as a potential drug target against virulent type of breast cancer, according to researchers at Cold Spring Harbor Laboratory.

Tumour cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 - also often called HER2 - that drives the cells to proliferate unchecked.


Patients unlucky enough to be in this group have poorer prognoses and clinical outcomes than those who don't.

The drugs Herceptin and Lapatinib, prescribed in combination with other chemotherapeutic agents, have improved this picture significantly, but leave plenty of room for improvement: they suppress ErbB2 but are effective against less than half of ErbB2-producing tumours.

Moreover, patients with tumours that do respond usually develop resistance to these drugs.

Now, a team of scientists has found that Brk could serve as a drug target to fight ErbB2-positive tumours.

The researchers said that Brk helps these tumours become virulent and is also implicated in the process through which the tumours develop drug resistance.

"The limited success of existing therapy suggested to us that factors besides ErbB2, or proteins that collude with ErbB2, might nullify the effects of Herceptin and Lapatinib," explained CSHL Professor Senthil Muthuswamy, Ph.D., leader of the research team and cor-author of the study.

In the hunt for ErbB2's co-conspirators, Muthuswamy's team focused on Brk, which they knew to be over-produced in many other types of cancer, including two-thirds of all breast cancers.

A detailed analysis of changes that occurred in the genomes of a sample of breast cancer patients helped the group confirm that the expression of ErbB2 and Brk was directly linked.

By forcing the production of both ErbB2 and Brk within the same cell, they determined how Brk enhances ErbB2 activity and fortifies tumour cells against ErbB2-targeting drugs.

"Our results might explain why the strategy of using ErbB2 inhibitors alone to treat breast cancers has fallen short. These findings may also suggest a way to treat patients with advanced ErbB2-positive tumours and those who've developed resistance to ErbB2 inhibitors - an idea that we're eager to test," said Dr. Muthuswamy.

The study is published online August 21 ahead of print in Proceedings of the National Academy of Sciences.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Drug Toxicity Pagets disease of the breast Otitis Media Mastitis Cancer and Homeopathy Clinical Trials - Different Phases of the trial Signature Drug Toxicity Breast Cancer Facts Cancer Facts 

Recommended Reading
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of ....
Breast Self Examination - Animation
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in ......
Clinical Trials - Different Phases of the trial
Clinical trials serve as a vital component for improving the treatment of medical conditions as they...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Otitis Media
Middle ear infection, or otitis media, is a common type of infection that may or may not accompany t...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use